Interestingly, while CFH rare variant carriers without AMD or with early/intermediate AMD showed significantly elevated C3bBbP levels compared to non-carriers, no such difference was observed between carriers and non-carriers with advanced AMD (Fig. 4D). This evidence concerns the gene CFH and age-related macular degeneration.